Other News To Note
Thursday, June 13, 2013
Neurovive Pharmaceuticals AB, of Stockholm, Sweden, said it inked a collaboration deal with Isomerase Therapeutics Ltd., of Cambridge, UK, to develop the molecules that were recently acquired from struggling UK firm Biotica Technology Ltd.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.